Screening of different probiotic strains for their in vitro ability to metabolise oxalates: Any prospective use in humans?

Journal of Clinical Gastroenterology

Volumn 48, Issue , 2014, Pages S91-S95

  Mogna, Luca ^a   Pane, Marco ^a   Nicola, Stefania ^a   Raiteri, Elisabetta ^a  

^a Biolab Research Srl   (Italy)

Author keywords

Hyperoxaluria; Kidney stones; Lactobacillus; Oxalates; Probiotic strains

Indexed keywords

AMMONIA; CALCIUM OXALATE; ENZYME; OXALIC ACID; OXALIC ACID DERIVATIVE; PROBIOTIC AGENT;

BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM; CONFERENCE PAPER; ENZYME METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPEROXALURIA; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; LACTOBACILLUS; METABOLISM; NONHUMAN; OXALOBACTER FORMIGENES; SCREENING; SPECIES; TOXICITY; URINARY EXCRETION; CLASSIFICATION; COMPARATIVE STUDY; INTESTINE; KINETICS; LITHIASIS; MICROBIOLOGY; REVERSED PHASE LIQUID CHROMATOGRAPHY;

BIFIDOBACTERIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; HUMANS; INTESTINES; KINETICS; LACTOBACILLUS; LITHIASIS; OXALIC ACID; PROBIOTICS;

EID: 84916611851     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000228     Document Type: Conference Paper

References (47)

1. Hodgkinson A. Oxalic Acid in Biology and Medicine. New York: Academic Press; 1977.
2. Williams HE, Wandzilak TR. Oxalate synthesis, transport and hyperoxaluric syndromes. J Urol. 1989;141(pt 2): 742-749.
3. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-462.
4. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86-e96.
5. Jeong IG, Kang T, Bang JK, et al. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 2011;58:383-388.
6. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011;79:1178-1185.
7. Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int. 2009;75:1264-1271.
8. Vervaet BA, Verhulst A, D'Haese PC, et al. Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant. 2009;24:2030-2035.
9. Rule AD, Bergstralh EJ, Melton LJ III, et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804-811.
10. Madore F, Stampfer MJ, Rimm EG, et al. Nephrolithiasis and risk of hypertension. Am J Hypertens. 1998;11(pt 1):46-53.
11. Rule AD, Roger VL, Melton LJ III, et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21:1641-1644.
12. Liebman M, Chai W. Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr. 1997;65: 1453-1459.
13. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001; 59:270-276.
14. Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985;11:267-269.
15. Trinchieri A. Diet and renal stone formation. Minerva Med. 2013;104:41-54.
16. Ferraz RR, Marques NC, Froeder L, et al. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients. Urol Res. 2009;37: 95-100.
17. Hatch M, Cornelius J, Allison M, et al. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int. 2006;69:691-698.
18. Hoppe B, von Unruh G, Laube N, et al. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res. 2005;33:372-375.
19. Gnanandarajah JS, Abrahante JE, Lulich JP, et al. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs. Urol Res. 2012;40:467-473.
20. Hoppe B, Dittlich K, Fehrenbach H, et al. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis. 2011;58:453-455.
21. Knight J, Deora R, Assimos DG, et al. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis. 2013;41:187-196.
22. Sidhu H, Enatska L, Ogden S, et al. Evaluating children in the Ukraine for colonization with the intestinal bacterium Oxalobacter formigenes, using a polymerase chain reactionbased detection system. Mol Diagn. 1997;2:89-97.
23. Magwira CA, Kullin B, Lewandowski S, et al. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group. J Appl Microbiol. 2012;113:418-428.
24. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62:787-796.
25. Iqbal MZ, Qadir MI, Hussain T, et al. Review: probiotics and their beneficial effects against various diseases. Pak J Pharm Sci. 2014;27:405-415.
26. Food and Agriculture Organization of the United Nations, World Health Organization. Guidelines for Evaluation of Probiotics in Food. London; Ontario, Canada; 2002.
27. Abratt VR, Reid SJ. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease. Adv Appl Microbiol. 2010;72:63-87.
28. Giardina S, Scilironi C, Michelotti A, et al. In vitro antiinflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria. J Food Sci. 2014;79:M384-M390.
29. Liebman M, Al-Wahsh IA. Probiotics and other key determinants of dietary oxalate absorption. Adv Nutr. 2011;2:254-260.
30. Al-Wahsh I, Wu Y, Liebman M. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects. Urol Res. 2012;40:191-196.
31. Okombo J, Liebman M. Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects. Urol Res. 2010;38:169-178.
32. Hungate RE. A roll tube method for cultivation of strict anaerobes. In: Norris JR, Ribbons DW, eds. Methods in Microbiology.3B: New York: Academic Press; 1969:117-132.
33. Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int. 2001;60:1097-1105.
34. Khaskhali MH, Bhanger MI, Khand FD. Simultaneous determination of oxalic and citric acids in urine by highperformance liquid chromatography. J Chromatogr B Biomed Appl. 1996;675:147-151.
35. Allison MJ, Dawson KA, Mayberry WR, et al. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol. 1985; 141:1-7.
36. Duncan SH, Richardson AJ, Kaul P, et al. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol. 2002;68:3841-3847.
37. Abe K, Ruan ZS, Maloney PC. Cloning, sequencing, and expression in Escherichia coli of OxlT, the oxalate:formate exchange protein of Oxalobacter formigenes. J Biol Chem. 1996;271:6789-6793.
38. Anantharam V, Allison MJ, Maloney PC. Oxalate:formate exchange. The basis for energy coupling in Oxalobacter. J Biol Chem. 1989;264:7244-7250.
39. Kang DC, Venkataraman PA, Dumont ME, et al. Oligomeric state of the oxalate transporter, OxlT. Biochemistry. 2011;50: 8445-8453.
40. Baetz AL, Allison MJ. Purification and characterization of formyl-coenzyme A transferase from Oxalobacter formigenes. J Bacteriol. 1990;172:3537-3540.
41. Sidhu H, Ogden SD, Lung HY, et al. DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes. J Bacteriol. 1997;179:3378-3381.
42. Lung HY, Baetz AL, Peck AB. Molecular cloning, DNA sequence, and gene expression of the oxalyl-coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes. J Bacteriol. 1994;176:2468-2472.
43. Ruan ZS, Anantharam V, Crawford IT, et al. Identification, purification, and reconstitution of OxlT, the oxalate: formate antiport protein of Oxalobacter formigenes. J Biol Chem. 1992;267:10537-10543.
44. Weese JS I, Weese HE, Yuricek L, et al. Oxalate degradation by intestinal lactic acid bacteria in dogs and cats. Vet Microbiol. 2004;101:161-166.
45. Turroni S, Bendazzoli C, Dipalo SC, et al. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes. Appl Environ Microbiol. 2010;76:5609-5620.
46. Azcarate-Peril MA, Bruno-Bárcena JM, Hassan HM, et al. Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. Appl Environ Microbiol. 2006;72: 1891-1899.
47. Turroni S, Vitali B, Bendazzoli C, et al. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J Appl Microbiol. 2007;103:1600-1609.